Burkhard Blank

Burkhard Blank formerly worked at Laurantis Pharma Oy, as Chief Executive Officer from 2013 to 2014, RIEMSER Pharma GmbH, as Director, Acorda Therapeutics, Inc., as Head-Drug Safety, Acorda Therapeutics, Inc., as Chief Medical Officer, Head-Research & Development from 2016 to 2021, Mersana Therapeutics, Inc., as Head-Clinical Development & Regulatory Affairs, MannKind Corp., as Chief Medical Officer, EVP-Research & Development from 2023 to 2025, Altus Pharmaceuticals, Inc., as Chief Medical Officer & Executive Vice President from 2006 to 2009, Boehringer Ingelheim Pharmaceuticals, Inc., as SVP-Medicine & Drug Regulatory Affairs from 2001 to 2006, Pharnext SA, as Chief Medical Officer, Head-Research & Development, and Herantis Pharma Oyj, as Chief Medical Officer.
Dr. Blank received his doctorate degree from Philipps University of Marburg.